Open AccessRecurrence of membranous nephropathy three weeks' postrenal transplant: A surprise in store
Author(s) -
Arun Kumar,
Praveen Murlidharan,
Sandeep Patil,
Satish Balan,
Ramdas Pisharody
Publication year - 2018
Publication title -
saudi journal of kidney diseases and transplantation/našrat amraḍ wa zira'aẗ al-kulaẗ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 30
eISSN - 2320-3838
pISSN - 1319-2442
DOI - 10.4103/1319-2442.235186
Subject(s) - medicine , incidence (geometry) , nephropathy , kidney transplantation , membranous nephropathy , disease , kidney , transplantation , kidney disease , urology , gastroenterology , surgery , glomerulonephritis , endocrinology , physics , optics , diabetes mellitus
Membranous nephropathy (MN) may occur in the transplanted kidney, either as recurrent disease in patients who had MN as the cause of end-stage renal disease (ESRD) in the native kidney or de novo, in patients who had another cause of ESRD initially. The reported incidence of recurrent MN ranges between 10% and 45%. Clinical manifestations of recurrent MN are typically observed 13-15 months after transplantation, although they may be observed much earlier (within weeks). Our patient had a recurrence in three weeks. Recurrent disease can lead to loss of the allograft.